Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril and Losartan in Diabetic Nephropathy
NCT00419835Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- May 2005
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of losartan in diabetic nephropathy (DN) (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Effect of treatment on proteinuria at 8 months. Started May 2005; status: completed.
02
Drugs
losartan
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00419835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00419835.